even report beat strength across portfolio manag
rais guidanc ep midpoint lot attent
mako multipl quarter grant solid
increasingli key trauma medsurg especi endoscopi neuro
continu put strong growth expect continu next year beyond second
margin improv stori increasingli materi manag call
minimum year first time ye expens
said believ name deserv premium valuat growth come
difficult comp believ momentum yield steadi upper singl digit revenu
growth plu double-digit ep growth top-tier larg cap med tech keep us
recommend name core hold
solid across board guidanc rais report result beat
top bottom line revenu beat consensu organ
growth ex adopt currenc underli ad back
one less sell day driven strength medsurg instrument endoscopi
knee physio under-perform rel expect adjust
ep tax benefit beat street second manag
rais revenu guidanc call organ growth exclud
adopt move opex sale higher
midpoint compani rais ep includ
entellu dilut favor currenc guid ep
street midpoint note assumpt one less sell
day number sell day rel
point call found two import piec call
discuss broad base strength busi mako-focus though
strong quarter well margin stori continu materi
sold mako robot quarter clearli take share tka market
result instal system competit account said
overlook strength trauma cc neuro medsurg endoscopi
particularli believ deserv much attent
come quarter year go forward anticip growth slow top-
line given difficult comparison believ quarter highlight sever area
strength expect strong growth potenti upsid segment
specif
second key take-away call oper margin expans stori
continu materi continu follow page
unexpect slowdown surgic volum price pressur
price close april
ep
debt total capit
piper jaffray seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis report read conjunct import disclosur inform
includ attest regul analyst certif found page report follow site
page
adjust revenu recognit impact adjust oper margin expand y/i
despit acquisit dilut even on-going dilut impact
acquisit invest oper growth manag confid well posit
deliv minimum note first time word minimum use
talk number believ margin expans stori compani may come
ahead expect coupl upper single-digit revenu growth drive
double-digit ep growth top-tier larg cap med tech
stock thought share trade meaning premium comp group
said believ deserv premium valuat growth like come
difficult comp believ momentum larg joint via mako neuro yield steadi
upper singl digit revenu growth come quarter believ maintain
premium multipl busi continu deliv solid financi result push
stock higher make name clean stori investor result
better expect result increas revenu guidanc margin commentari
increas price target multipl revis ep result
increas pt
page
page
good gener incom net incom tax net incom analysi gross gener million stryker corpor
million except per share data
good sold
percent sale
good sold
current disclosur inform compani locat http //www piperjaffray com/researchdisclosur
